Number of the records: 1
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy
- 1.0346751 - ÚMG 2011 RIV GR eng J - Journal Article
Bubeník, Jan - Šímová, Jana
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy.
Journal of Balkan Union of Oncology. Roč. 14, č. 1 (2009), s. 169-173. ISSN 1107-0625. E-ISSN 2241-6293
R&D Projects: GA ČR GA301/06/0774; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : residual tumour disease * HPV16 * cellular vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.600, year: 2009
Permanent Link: http://hdl.handle.net/11104/0187687
Number of the records: 1